Riskpilot← Back to searchSign inGet full accessZoetis Sweden AB
ABActiveOrg 5566185863StockholmManufacture of other special-purpose machinery n.e.c. · NACE 2899Est. 20014 employees
Revenue 2024
SEK 13M
+19% vs 2023
EBITDA margin
5.3%
-34% vs 2023
Equity ratio
56.3%
Financial strength
Net profit 2024
SEK 403K
-34% vs 2023
| Revenue | SEK 13M | +19% |
| EBITDA | SEK 684K | -34% |
| Net profit | SEK 403K | -34% |
| Total assets | SEK 4,3M | +33% |
| Equity | SEK 2,4M | +20% |
| Employees | 4 | — |
Legal name
Zoetis Sweden AB
Org number
5566185863
Legal form
Aktiebolag
NACE code
2899 · Manufacture of other special-purpose machinery n.e.c.
Founded
28 november 2001
Share capital
SEK 100 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall marknadsföra och tillhandahålla varor och tjänster relaterade till (i) diagnostiska produkter, (ii) kosmetiska produkter, samt (iii) läkemedel, vaccin och andra produkter inom läkemedels området, och bedriva därmed förenlig verksamhet.
Address
Stockholm
Phone
+4631296346
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 820 | 11 829 | 11 076 | 10 917 | 13 019 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 17 | 1 196 | 738 | 1 043 | 684 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 17 | 1 196 | 738 | 1 043 | 684 |
| Net financials | −1 | −1 | −2 | −58 | −15 |
| Profit before tax | 15 | 1 196 | 736 | 985 | 669 |
| Tax | −36 | −337 | −284 | −370 | −266 |
| Net profit | −21 | 859 | 452 | 615 | 403 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 598 | 3 801 | 4 265 | 3 226 | 4 279 |
| Equity | 80 | 939 | 1 391 | 2 006 | 2 409 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 518 | 2 862 | 2 874 | 1 221 | 1 871 |
| Total debt | 1 518 | 2 862 | 2 874 | 1 221 | 1 871 |
EBITDA margin
5.3%
This company
15.8%
Market median
-66% vs market
20202024
Equity ratio
56.3%
This company
38.2%
Market median
+47% vs market
20202024
Return on equity
16.7%
This company
18.4%
Market median
+9% vs market
20202024
Net profit margin
3.1%
This company
8.1%
Market median
-62% vs market
20202024
Asset turnover
3.04×
This company
1.12×
Market median
+171% vs market
20202024
Debt / equity
0.78×
This company
0.62×
Market median
+26% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JG Chief Auditor | Chief Auditor | 2022 |
TS Chief Executive Officer | Chief Executive Officer | 2021 |
ML Authorized Recipient of Service | Authorized Recipient of Service | 2024 |
| Former (3) | ||
EK | Audit | 2020 – 2022 |
RI Authorized Recipient of Service | Authorized Recipient of Service | 2020 – 2021 |
JA Authorized Recipient of Service | Authorized Recipient of Service | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Former (6) | ||
| Board of Directors | 2021 – 2022 | |
| Chairman | 2022 – 2025 | |
| Deputy Board Member | 2020 – 2021 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2020 – 2021 | |
| Chairman | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PHARMAQ FISHTEQ AS
Zoetis Sweden AB (this company)Board members of Zoetis Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jimmy Gustav Almqvist | Chief Auditor | 0 companies |
| Thomas Schmidt Hilligsøe | Chief Executive Officer | 0 companies |
| Emil Karl-Gustaf Berglund | Audit | 0 companies |
| Renata Izabela Bader | Authorized Recipient of Service | 0 companies |
| Johannes Anders Christoffer Larsson | Authorized Recipient of Service | 0 companies |
| Mariel Lydia Selin | Authorized Recipient of Service | 0 companies |
| Carl Johan Vilhelm Ehn | Board of Directors | 0 companies |
| Stephanie Armstrong | Chairman | 0 companies |
| Remy Oddoy | Deputy Board Member | 0 companies |
| Ben Backmann | Board of Directors | 0 companies |
| Jorn Ståle Pettersen | Board of Directors | 0 companies |
| Luis Sebastian Handorf | Board of Directors | 0 companies |
| Gondje Henrica Martine Hendriks | Chairman | 0 companies |
| Jamie Andrew Brannan | Chairman | 0 companies |